Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Blaise

Showing results (191-200 of 284) with videos related to

Pageof 29
Sort By:
Bone Marrow Transplantation|December 11, 2012
Disease status is a more reliable predictive factor than histology in lymphoma patients after reduced-intensity conditioning regimen and allo-SCTL Castagna, R Boubdallah, S Furst, et al.
Bone Marrow Transplantation|October 6, 2015
Second reduced intensity conditioning allogeneic transplant as a rescue strategy for acute leukaemia patients who relapse after an initial RIC allogeneic transplantation: analysis of risk factors and treatment outcomesR Vrhovac, M Labopin, F Ciceri, et al.
Journal of Internal Medicine|December 19, 2018
Cord blood transplantation is associated with good outcomes in secondary Acute Myeloid Leukaemia in first remissionF Baron, M Labopin, A Ruggeri, et al.
Bone Marrow Transplantation|March 9, 2004
Multivariate analysis of survival in inflammatory breast cancer: impact of intensity of chemotherapy in multimodality treatmentF Bertucci, C Tarpin, E Charafe-Jauffret, et al.
Bone Marrow Transplantation|November 9, 2004
Stem cell transplantation from identical twins in patients with myelodysplastic syndromesN Kröger, R Brand, A van Biezen, et al.
Bone Marrow Transplantation|November 14, 2017
Impact of HLA-G polymorphism on the outcome of allogeneic hematopoietic stem cell transplantation for metastatic renal cell carcinomaR Crocchiolo, O Ringden, J-O Bay, et al.
Bone Marrow Transplantation|July 8, 2014
Reduced-intensity conditioning regimen with in vivo T-cell depletion for patients with haematological malignancies: results using unrelated and sibling donorsL Castagna, R Crocchiolo, S Furst, et al.
Leukemia|October 23, 2009
Influence of NPM1 and FLT3-ITD status on outcome in relapsed/refractory AML patients receiving salvage therapy including gemtuzumab ozogamicinP Chevallier, T Prebet, A Pigneux, et al.
Bone Marrow Transplantation|August 6, 2008
Outcome after reduced-intensity conditioning allogeneic SCT for AML in first complete remission: comparison of two regimensX Cahu, M Mohty, C Faucher, et al.
Bone Marrow Transplantation|June 11, 2013
Efficacy and safety of micafungin for prophylaxis of invasive fungal infections in patients undergoing haplo-identical hematopoietic SCTJ El-Cheikh, G Venton, R Crocchiolo, et al.
Pageof 29

Showing results (191-200 of 284) with videos related to

Sort By:
Pageof 29
Bone Marrow Transplantation|December 11, 2012
Disease status is a more reliable predictive factor than histology in lymphoma patients after reduced-intensity conditioning regimen and allo-SCTL Castagna, R Boubdallah, S Furst, et al.
Bone Marrow Transplantation|October 6, 2015
Second reduced intensity conditioning allogeneic transplant as a rescue strategy for acute leukaemia patients who relapse after an initial RIC allogeneic transplantation: analysis of risk factors and treatment outcomesR Vrhovac, M Labopin, F Ciceri, et al.
Journal of Internal Medicine|December 19, 2018
Cord blood transplantation is associated with good outcomes in secondary Acute Myeloid Leukaemia in first remissionF Baron, M Labopin, A Ruggeri, et al.
Bone Marrow Transplantation|March 9, 2004
Multivariate analysis of survival in inflammatory breast cancer: impact of intensity of chemotherapy in multimodality treatmentF Bertucci, C Tarpin, E Charafe-Jauffret, et al.
Bone Marrow Transplantation|November 9, 2004
Stem cell transplantation from identical twins in patients with myelodysplastic syndromesN Kröger, R Brand, A van Biezen, et al.
Bone Marrow Transplantation|November 14, 2017
Impact of HLA-G polymorphism on the outcome of allogeneic hematopoietic stem cell transplantation for metastatic renal cell carcinomaR Crocchiolo, O Ringden, J-O Bay, et al.
Bone Marrow Transplantation|July 8, 2014
Reduced-intensity conditioning regimen with in vivo T-cell depletion for patients with haematological malignancies: results using unrelated and sibling donorsL Castagna, R Crocchiolo, S Furst, et al.
Leukemia|October 23, 2009
Influence of NPM1 and FLT3-ITD status on outcome in relapsed/refractory AML patients receiving salvage therapy including gemtuzumab ozogamicinP Chevallier, T Prebet, A Pigneux, et al.
Bone Marrow Transplantation|August 6, 2008
Outcome after reduced-intensity conditioning allogeneic SCT for AML in first complete remission: comparison of two regimensX Cahu, M Mohty, C Faucher, et al.
Bone Marrow Transplantation|June 11, 2013
Efficacy and safety of micafungin for prophylaxis of invasive fungal infections in patients undergoing haplo-identical hematopoietic SCTJ El-Cheikh, G Venton, R Crocchiolo, et al.
Pageof 29